SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-091346
Filing Date
2024-08-20
Accepted
2024-08-20 18:05:08
Documents
2
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2422185-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2422185-1_4seq1.xml 4 13800
2 EXHIBIT 24 tm2422185d1_ex24.htm EX-24 10127
  Complete submission text file 0001104659-24-091346.txt   25579
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address
Drutz David (Reporting) CIK: 0001428764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 241226575